Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Peiris

Showing results (581-590 of 585) with videos related to

Pageof 59
Sort By:
You have reached the last page of results.This site can display upto 585 results.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
Plos Pathogens|April 15, 2020
Characterizing Emerging Canine H3 Influenza VirusesLuis Martinez-Sobrido, Pilar Blanco-Lobo, Laura Rodriguez, et al.
Pageof 59

Showing results (581-590 of 585) with videos related to

Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 585 results.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
Plos Pathogens|April 15, 2020
Characterizing Emerging Canine H3 Influenza VirusesLuis Martinez-Sobrido, Pilar Blanco-Lobo, Laura Rodriguez, et al.
Pageof 59